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Purpose: We investigated the mechanical characteristics of lyophilized human saphenous 
vein valves to determine their suitability for use as aUogeneic transplants o treat chronic 
venous insufficiency. 
Methods: Fresh cadaveric veins were lyophilized in vacuum bottles within 24 hours of 
harvest and were stored at room temperature. The veins were reconstituted in saline 
solution and then were placed in an in vitro flow circuit for evaluation. At varied flow 
rates, pressures proximal and distal to valves during prograde and retrograde flow were 
measured. Valve closure times were determined with Doppler examination and spectral 
analysis. The valves were also stressed to 350 mm Hg on a separate apparatus. 
Results: All pressures proximal and distal to the valves remained less than 10 mm Hg 
during prograde flow. A pressure gradient developed immediately on the reversal of flow. 
Pressure as high as 200 mm Hg applied against he closed valves was not transmitted 
beyond the valve. Valve closure times had a mean of 0.31 -+ 0.03 seconds and 0.21 - 
0.01 seconds for the Doppler examination and spectral analysis, respectively. All valves 
withstood stress pressures to 350 mm Hg. 
Conclusions: The in vitro mechanical characteristics of the valves of lyophilized veins are 
similar to known values for normal in vivo valves. (J Vasc Surg 1997;26:823-8.) 
Chronic venous insufficiency affects more than 7 
million people in the United States, and at least 
500,000 of these have leg ulceration. 1 Valvular eflux 
is the most common cause of chronic venous insuffi- 
ciency and involves the deep venous system in more 
than 70% of patients who have severe, stage I I I  dis- 
ease. 2,3 Valvular reflux leading to chronic venous 
insufficiency can be congenital but most commonly 
results from primary valvular incompetence or the 
postthrombotic syndrome. Primary valvular incom- 
petence is caused by a laxity in the valve cusps or a 
weakened venous wall that prevents leaflet coapta- 
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tion, whereas the postthrombotic syndrome is asso- 
ciated with the postthrombotic destruction of valves 
after venous obstruction and rccanalization. 4-6 Ve- 
nous insufficiency requires treatment when symp- 
tomatic, particularly when complicated by venous 
stasis ulceration. Treatment since the time of Hip- 
pocrates has been nonoperative, consisting of  eleva- 
tion, compression, and topical therapy. 
A surgical alternative for those patients who have 
significant demonstrable reflux and class II or Ill 
disease (SVS/ISCVS reporting standards, 1988) is 
restoration or replacement of incompetent valves, s 
Direct repair of redundant or "floppy" incompetent 
valve cusps has been reported to result in a 63% to 
90% rate of Ulcer healing without recurrence over 2- 
to 5-year follow-up. 9Valvuloplasty is the procedure 
of choice for primary valvular insufficiency with re- 
constructible valves; however, it is technically de- 
manding and highly operator-dependent. 3 
Venous wall support with a synthetic uff is an 
option for surgical correction of valve incompetence 
that corrects with vasospasm. 5 This technique is suc- 
cessful when vein dilatation prevents valve leaflets 
from approximating atclosure. Reducing the lumen 
size with external support allows for proper valve 
coaptation. 
When postthrombotic destruction of valves ren- 
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Fig. 1. In vitro steady-state flow circuit. 
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ders them insufficient and unsuitable for valvulo- 
plasty, surgical treatment includes valve transposition 
or transplantation) ° Valve replacement with trans- 
posed axillary vein has not been as durable as valvu- 
loplasty. Axillary vein transposition achieves an initial 
ulcer healing rate of 83%, decreasing to less than 50% 
after 2 years. 7The failure of transposed axillary vein 
valves is a result of gradual dilatation and fibrosis of 
the transposed valves. This has been attributed to a 
compliance mismatch that occurs when placing the 
highly compliant axillary venous segment into a 
poorly compliant postthrombotic system. 7,11 Other 
factors that may complicate vein transposition are 
incompetence of harvested axillary vein valves, size 
mismatch, morbidity of vein harvest, and nonavail- 
ability of valves for multiple or repeat ransplants. 12 
Despite these potential problems, this technique re- 
mains the best option for patients who have absent or 
destroyed valves.l° 
Autogenous veins are the best source of trans- 
planted valves, but these are absent or unsuitable in 
20% to 30% of patients) s Allogeneic valve trans- 
plants have been attempted, but results are disap- 
pointing. Transplants are plagued with antigenicity 
and subsequent deterioration from immunologic re- 
jection. 14,is Transplanted valves that are glutaralde- 
hyde-fixed are less immunogenic but do not exhibit a 
preservation of structural integrity) s Cryopreserva- 
tion of allograft veins has been shown to preserve the 
structure and function of fresh veins to be used as 
transplants) 6 Preservation of structure, however, 
also preserves the cellular components of the vein 
and renders the transplants.antigcnic. 17,1s Chronic 
rejection may then orchestrate the same degenera- 
tion that is seen in cryopreserved veins used as arterial 
conduits) 7,19 Because of antigenicity, patients who 
receive cryopreserved veins as vascular substitutes are 
being immunosuppressed and may require ABO 
blood group and histocompatibility matching. 15-19 
Still in developmental stages, investigators have had 
early success in manufacturing biocompatible pros- 
thetic valves. Prosthetic valves became hampered by 
degenerative changes or intimal hyperplasia nd 
eventually became functionless. 2°-22 
Clearly apparent is a need for an alternative to 
currently available options that address chronic ve- 
nous insufficiency. Veins obtained from cadavers pre- 
served with lyophilization are an attractive source of 
valves for homologous transplantation. The freeze- 
drying process renders the tissue nonimmuno- 
genic. 23 Once reconstituted, lyophilized vessels dem- 
onstrate handling characteristics quite similar to fresh 
veins. 24 These allografts demonstrate patency and 
structural integrity in both the arterial and venous 
systems. 23-28 This project investigates the suitability 
of transplanted lyophilized veins for the treatment of 
chronic venous insufficiency by examining the me- 
chanical competency of the valves after lyophiliza- 
t ion .  
METHODS 
Human greater saphenous vcins were obtained 
from cadaveric donors. The donors had no known 
history of venous insufficiency or venous thrombosis, 
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Fig. 2. Duplex scan with spectral analysis of a lyophilized vein during flow reversal. Prograde 
flow is depicted on negative y axis and becomes positive as flow reverses. Valve closure time is 
measured on x axis as the time between flow reversal and flow cessation using time scale 
(0.04-second increments) atbottom of recording. 
and all died from unrelated causes. After harvest, 20 
cm segments ofvein were irrigated with a 1% papav- 
erine/saline solution to remove blood and debris. 
They were stored at 4 ° C in RPMI 1640 (Roswell 
Park Memorial Institute) until processed. Within 24 
hours of harvest he veins were placed in vacuum 
bottles with 20 ml RPMI 1640 and frozen in a 
-60°C refrigerator (Forma Ultralow; Marietta, 
Ohio). The frozen veins were lyophilized at -30 ° C 
with a vacuum of 1 mm Hg until completely dry by 
inspection (approximately 72 hours). Before in vitro 
testing, the veins were rehydrated in 20 ml Hank's 
buffered saline solution for 30 minutes at room tem- 
perature. The time interval from lyophilization to 
rehydration ranged from 3 to 6 months. 
Six veins were alternatively placed into an in vitro 
flow circuit (Fig. 1) and perfused with room-temper- 
ature saline solution. The pressure on either side of 
each valve was examined uring prograde and retro- 
grade flow and at the time of valve closure with 
intravenous pressure transducers attached to 22- 
gauge needles (Stryker, Hewlett-Packard). A flow 
meter was used to monitor flow rates (Transonic 
Systems, Inc.; Ithaca, N.Y.). Pressures were mea- 
sured after each incremental f ow increase from 25 
ml/min to as high as 200 ml/min. 
Valve closure time was assessed for these same 
valves using a handheld analog Doppler and chart 
recorder (Medasonics; Mountainview, Calif.). The 
flow was manually reversed with a syringe attached to 
a T-connector in the flow circuit at the outflow end 
of the vein. Fluid injected by the syringe was forced 
in both prograde and retrograde directions through 
the T-connector and the circuit, simulating a Val- 
salva maneuver. The time from flow reversal until 
cessation of flow was used as a measure of valve 
closure time.Z9 Valve closure times were also assessed 
in six additional lyophilized veins using color Dopp- 
ler and spectral analysis (Ultramark 9; ATL, Inc.; 
Bothell, Wash.; Fig. 2). 
Seven valves from different veins were stressed to 
350 mm Hg using air pressure. The proximal end of  
each vein segment and a syringe were attached to a 
pressure transducer (Grass Model PT300, West War- 
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pressure transducer 
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Fig. 3. Maximum pressure testing. A valve leak is demon- 
strated by escaping air. 
wick, R.I.) and a physiologic monitor (Grass Model 
7400; Fig. 3). This arrangement allowed pressure to 
be monitored as it was applied retrograde through 
the vein against a closed valve. The distal end of the 
vein was submerged in water to reveal any air escap- 
ing across the closed valve as evidence of a leak. A 
maximum pressure of 350 mm Hg was applied to 
each valve. 
RESULTS 
The pressure on either side of the valves remained 
less than 10 mm Hg at prograde flow rates as high as 
200 ml/min. A pressure gradient across the valves 
could not be detected at any flow rate. Flow reversal 
and a pressure gradient developed immediately when 
saline solution was injected into the system via the 
T-tube connector at the outflow end of  the vein. 
Pressure was applied as high as 200 mm Hg proximal 
to the closed valve, with pressure distal to the valve 
remaining less than 10 mm Hg, thus indicating a 
competent valge. All valves consistently closed at 
retrograde flows of less than 2 ml/min. 
Valve closure times had a range of 0.2 to 0.62 
seconds, with a mean of 0.31 ___ 0.03 seconds (n = 
18) when measured with a handheld analog Dopp- 
ler. Valve closure time of the additional valves mea- 
sured with a duplex scanner anged from 0.16 to 
0.28 seconds, with a mean of  0.21 _+ 0.0]~ seconds 
(n = 18), corroborating the initial Doppler findings. 
All valves stressed with pressure withstood the 
maximum pressure applied of 350 mm Hg without 
complete failure. One of the valves developed a leak 
at sustained pressures above 140 mm Hg but still 
tolerated the maximum pressure. 
DISCUSSION 
Valve closure times of normal veins are less than 
0.5 seconds? ° The valve closure times of the lyophi- 
lizecl valves were within that limit. The lyophilized 
valves withstood stress in vitro to 350 mm Hg with- 
out failure. The sustained proximal pressure against a
closed normal valve in vivo can approximate 100 mm 
Hg. 31 One valve had a leak at pressures exceeding 
140 mm Hg, but this leak occurred only at pressures 
well above what is experienced in vivo. The lyophi- 
lized valves were not altered in a manner that would 
impede prograde flow or require a significant pres- 
sure gradient o open or close. These data support 
our hypothesis that the mechanical characteristics of
valves in lyophilized veins in vitro are similar to 
known characteristics of normal valves in vivo? 1,32 
Immunogenicity plays a significant role in the 
fate of allografted veins. 13A9,33-36 The source of the 
immunogenicity is thought o be the class I and II 
antigens on vascular endothelial cells, but all cellular 
components are suspect because flbroblasts and 
smooth muscle cells also express class II antigens, is
Our group has previously demonstrated the impor- 
tance of antigenicity to allograft patency, showing 
that patency is related to the degree of major histo- 
compatibility complex match and the development 
of cytotoxic antibodies. We have compared cryopre- 
served allografts used as arterial conduits in matched, 
one-haplotypc mismatch, and mismatched immuno- 
logically defined miniswine. The patency rate was 
higher and the development ofantibody was lower in 
matched grafts? 7Marois et al. 28 had similar findings 
with allografted veins used as arterial conduits in 
matched and unmatched canines, finding lower pa- 
tency rates and decreased functioning of the cellular 
elements of mismatched grafts. The mismatched 
grafts exhibited a lower prostacyclin/thromboxane 
ratio compared with autografts- and tissue-matched 
controls. 28 
Lyophilized veins are devoid of cellular elements, 
leaving a collagenous nonimmunogenic conduit. We 
previously demonstrated in canines the nonimmuno- 
genicity of lyophilized veins and the feasibility of 
their use as vascular conduits. 23 Although exposed 
collagen is considered thrombogenic, we showed the 
patency rate of allografted freeze-dried veins in dogs 
to bc similar to ftcsh autografted veins in aortic and 
caval interposition grafts, femoral arteriovenous fi - 
tulas, and mesocaval shunts. Preservation of graft 
cellularit T is thought o be important for maintaining 
patency and structural integrity; however, previous 
studies by this group have found lyophilized aortic 
interposition allografts patent for 1 year. 25 These 
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explants exhibited incorporation into surrounding 
tissues with luminal endothelialization. Further- 
more, we have shown freeze-dried veins to be non- 
immunogenic in microcytotoxicity assays that com- 
pared fresh, freeze-dried, frozen, and cryoprotected 
frozen veins. 2s The fresh and cryopreserved vein allo- 
grafts incited antibody product ion in study animals, 
whereas the noncryoprotected frozen and the freeze- 
dried veins, each with decreased cellularity, did not  
provoke an antibody response. 
There are several potential advantages to the use 
oflyophil ized valves for transplantation over autoge- 
nous valves or transplants preserved by other meth- 
ods. Valves in lyophilized veins are nonantigenic, so 
they would be spared the degenerative consequences 
of  tissue rejection. Immunosuppression f  the recip- 
ients would not be required. The size and compli- 
ance mismatches between axillary and lower extrem- 
ity veins could be eliminated, and the morbidity 
associated with the harvest ofaxillary vein transplants 
avoided) 2 In patients who have undergone previous 
valve transplantation and no longer have an autoge- 
nous source of  valves available, lyophilized veins 
would serve as a readily available valve source. Evi- 
dence mounts implicating infrapopliteal and deep 
system reflux as a major component  o f  the pathogen- 
esis o f  chronic venous insufficiency, leading some 
to propose repair or replacement o f  multiple 
ValVeS. 6'12'38-39 Multiple valve transplants would sel- 
dom be possible with valves from autogenous 
sources, but lyophilized allogeneic transplants would 
provide multiple valves in appropriate sizes. 
Lyophil ized veins retain their collagen structure 
and orientation, and collagen IV is a significant com- 
ponent  o f  the extracellular matrix, thus malting ly- 
ophilized veins attractive for autogenous eeding? 3 
This could be beneficial when transplanting valves to 
inhospitable locales such as the infrageniculate ves- 
sels or to low-flow sites bypassing venous obstructive 
disease. Lyophil ized veins are readily available and 
inexpensive compared with other preserved veins. 
They can be harvested uring the harvest o f  other 
cadaveric organs and tissues. Easily stored and trans- 
ported at room temperature with a shelf life o f  more 
than 2 years, a bank of  veins could be easily devel- 
oped and maintained. 24 
Long-term patency, thrombogenicity, and dura- 
bility remain to be evaluated, but in vitro the valves 
of  lyophilized veins function with the characteristics 
o f  normal valves. An appealing source of  valves for 
transplantation, lyophilized valves warrant further in- 
vestigative studies. 
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